###### What is already known?

-   A higher volume of physical activity is associated with lower mortality risk, but it is unknown whether vigorous activity may yield larger reductions on mortality risk than energy-matched activities of lower intensity.

###### What is the new finding?

-   In this cohort, vigorous physical activity was associated with larger reductions on all-cause mortality risk than activities of lower intensity.

-   No evidence of dose-response effects on reductions of mortality was found with vigorous activities. For cancer mortality risk, no conclusive evidence was found about the role of vigorous activities.

Background {#s1}
==========

The health benefits of physical activity are well established.[@R1] Physical inactivity is the fourth leading risk factor for global mortality,[@R2] causing an estimated 5.3 million deaths per year.[@R3] Guidelines from the USA,[@R4] UK,[@R5] Australia[@R6] and the WHO[@R7] recommend that to achieve significant health benefits, including a lower mortality risk, adults should accumulate at least 150 min of moderate activity (3--5.9 metabolic equivalent tasks, METs), or 75 min of vigorous activity (≥6 METs) per week, or a combination of both where 1 min of vigorous activity counts approximately the same as 2 min of moderate intensity activity. This implies that when the overall activity energy expenditure is held constant, moderate and vigorous intensity activities produce similar health benefits. However, activities of at least vigorous intensities are required to improve or maintain cardiorespiratory fitness in healthy populations,[@R8] which is considered a powerful predictor of clinical outcomes[@R14] and mortality.[@R15]

To date, few epidemiological studies have examined the association between the intensity of physical activity and mortality while controlling for the volume of activity, yielding mixed results.[@R20] While some prospective studies found a lower risk in all-cause[@R20] and cardiovascular disease (CVD) mortality[@R21] in participants reporting larger proportions of vigorous intensity, another study found inconsistent associations with CVD mortality in both sexes and a reduction in all-cause mortality only in men.[@R22] Regarding the influence of physical activity on cancer, a recent meta-analysis[@R25] observed an inverse association between the volume of physical activity and the risk of cancer mortality.

To our knowledge, no previous epidemiological studies have examined the role of vigorous activity (vs moderate and holding constant total physical activity) in cancer mortality.

Using data from a series of large British cohorts, we examined whether the proportion of total physical activity accrued by vigorous activities was associated with all-cause, CVD and total cancer mortality independent of the total amount of activity.

Methods {#s2}
=======

Population {#s2-1}
----------

The Health Survey for England (HSE) and the Scottish Health Survey (SHeS) are household-based prospective studies in which households were selected using a multistage, stratified probability design to achieve representative samples of the population of England and Scotland. Stratification was based on geographical characteristics (postcode sectors were selected at the first stage). Local research ethics committees approved the data collection of each survey. The present study included 11 population cohorts of individuals aged 30 years or older: HSE 1994, 1997, 1998, 1999, 2003, 2004, 2006 and 2008; SHeS 1995, 1998 and 2003.[@R26] For this study, we excluded all individuals that reported no moderate-to-vigorous physical activity (MVPA) and/or did not provide information for any of the covariates included in the statistical models.

Measurement of exposure {#s2-2}
-----------------------

Physical activity was measured by an interviewer-administered questionnaire as described elsewhere.[@R28] Participants were asked about the frequency, duration and pace of walking (slow, average or brisk) and domestic physical activity. In addition, data on physical activity in sports and exercise were collected (frequency, duration and perceived intensity over the last 4 weeks) using a prompt card. This contained 10 main groupings, including cycling, swimming, running, football, rugby, tennis and squash. Up to six open entries could be recorded. Perceived moderate intensity activities correspond to a slight increase in the heart rate (3.0--5.9 METs), whereas vigorous activities get people out of breath and make them sweat (6.0 or more METs, where 1 MET represents the resting energy expenditure).[@R4] The criterion validity of the physical activity questionnaire used in the HSE has been described previously.[@R29]

Measurement of the outcomes {#s2-3}
---------------------------

The British National Health Service Central Registry flagged all participants. Primary cause of death was determined based on the codes from the International Classification of Diseases, Ninth Revision (ICD-9) and the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). CVD mortality codes were 390 to 459 for ICD-9 and I01 to I99 for ICD-10, and for cancer mortality were 140 to 239 for ICD-9 and C00 to D48 for ICD-10.

Covariates {#s2-4}
----------

Height and weight were measured objectively by trained interviewers following standard protocols.[@R26] Body mass index (BMI) was calculated as weight in kilograms divided by height in metres squared. Then, we categorised participants as normal weight (BMI \<25) and overweight/obese (BMI ≥25). Education level was assessed as the age at which each participant finished full-time education (recoded into ≤15, 15--18 and ≥19 years old). For alcohol consumption, researchers asked the frequency of drinking during the last week (recoded into \<5 or ≥5 times/week). Smoking status was categorised as never or ex-regular or ex-occasional or current smoker. Longstanding illness was defined when individuals had at least one illness within a list of illnesses affecting different body systems (ie, the nervous system, heart and circulatory system). Cancer or CVD (angina, stroke and coronary heart disease) diagnosis was based on medical reports. The General Health Questionnaire (GHQ-12) was used to assess psychological distress which is considered a valid tool.[@R30]

Statistical analysis {#s2-5}
--------------------

Cox proportional hazards regression models were used to estimate the association between the proportion of total weighted MVPA as vigorous activity and all-cause, CVD and cancer mortality. We examined the proportional hazards assumption and, as statistical tests were violated (χ^2^=28.43, p=0.0002), we alternatively used stratified Cox proportional regression models. By doing so, no violations were noted (χ^2^=4.35, p=0.23). Cox models were stratified by age, sex, education and smoking and adjusted for alcohol consumption, total weighted volume of MVPA and longstanding illness. For the outcome CVD mortality, models were additionally adjusted for CVD diagnosis at baseline. For cancer mortality, models were additionally adjusted for cancer diagnosis at baseline. To account for potential reverse causation through occult disease at baseline, analyses were repeated excluding those subjects who died during the first 24 months of follow-up. We created the variable 'proportion of weighted MVPA by vigorous activity' (three levels) based on the cut-points used in two previous publications[@R23]: (1) 0%; (2)\>0% to \<30%; and (3) ≥30% of MVPA by vigorous activity.

Sensitivity analyses were also performed to account for additional confounders. Model 1 was additionally adjusted for BMI. Model 2 included model 1 plus psychological distress. Because of the relatively small size of the \>0% to \<30% of MVPA by vigorous physical activity group, we also regrouped the exposure variable using a distribution-driven approach to elicit more equal groups: 0% of vigorous; \> 0 to \<60% of physical activity as vigorous: \>60% of MVPA as vigorous ([online supplementary table 2](#SP2){ref-type="supplementary-material"}). Finally, we explored associations comparing the highest intensity level achieved by participants versus moderate intensity ([online supplementary table 3](#SP3){ref-type="supplementary-material"}). All analyses were performed with the statistical package STATA V.14 (StataCorp, College Station, Texas, USA).
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Results {#s3}
=======

Descriptive characteristics of the sample are shown in [table 1](#T1){ref-type="table"}. Of the 64 913 adult respondents, 56% were women, 59.5% were overweight or obese, 75.8% were non-current smokers, 80% did not drink alcohol frequently (less than five times per week) and 84.7% did not report psychological distress. More than half (58.3%) of the participants met the WHO's physical activity recommendations[@R7] of 150 min of weighted MVPA per week. Of those who engaged in any MVPA, 68.6% did not report any vigorous activity, 7.7% reported less than 30% and 23.7% reported 30% or more of their total MVPA as vigorous activity. The highest total volume of physical activity was in the 0%--30% vigorous group, who reported a median of 461 min per week of MVPA. Participants who were younger, male and sufficiently active were more likely to engage in some vigorous activity. The main analyses included 64 913 (all-cause mortality), 57 702 (CVD mortality) and 63 677 (cancer mortality) participants.

###### 

Characteristics of participants at baseline (n=64 913) in the Health Survey for England and Scottish Health Survey

  -------------------------------------------------------------------------------------------------------------------
  Number (%) of participants                                                                         
  ----------------------------------------- ----------------- ------------------- ------------------ ----------------
  Total sample, n (%)                       44 521 (68.6)     5000 (7.7)          15 392 (23.7)      64 913

  Sex, n (%)                                                                                         

   Male                                     18 421 (64.5)     2341 (8.2)          7805 (27.3)        28 567

   Female                                   26 100 (71.8)     2659 (7.3)          7587 (20.9)        36 346

  Age group, y                                                                                       

   30--49                                   20 363 (58.3)     3521 (10.1)         11 024 (31.6)      34 908

   50--64                                   14 441 (75.8)     1202 (6.3)          3413 (17.9)        19 056

   65-max                                   9717 (88.7)       277 (2.5)           955 (8.7)          10 949

  Age finished full-time education,\                                                                 
  n (%)                                                                                              

   ≤15 y                                    18 216 (82.8)     1042 (4.7)          2745 (12.5)        22 003

   16--18 y                                 19 329 (64.8)     2617 (8.8)          7876 (26.4)        29 822

   ≥19 y                                    6976 (53.3)       1341 (10.2)         4771 (36.5)        13 088

   Smoking status, n (%)                                                                             

   Non-current                              32 508 (66.1)     3930 (8.0)          12 736 (25.9)      49 174

   Current                                  12 013 (76.3)     1070 (6.8)          2656 (16.9)        15 739

  Alcohol consumption frequency,\                                                                    
  n (%)                                                                                              

   \<5 times/week                           35 979 (68.8)     3953 (7.6)          12 317 (23.6)      52 249

   ≥5 times/week                            8542 (67.4)       1047 (8.3)          3075 (24.3)        12 664

  Long-standing illness, n (%)                                                                       

   No                                       24 071 (64.8)     3178 (8.5)          9906 (26.7)        37 155

   Yes                                      20 450 (73.7)     1822 (6.5)          5486 (19.8)        27 758

  Weighted MVPA, min/week                                                                            

   10--149                                  23 126 (85.7)     485 (1.8)           3380 (12.5)        26 991

   ≥150                                     21 362 (56.5)     4496 (11.9)         11 960 (31.6)      37 818

   Median physical activity levels (IQRs)   195 (80--442.5)   137.5 (60--322.5)   461.4 (255--817)   329 (165--615)

  BMI, n (%)                                                                                         

   \<25 (normal weight)                     17 941 (67.1)     2189 (8.2)          6603 (24.7)        26 733

   ≥25 (overweight/obesity)                 26 902 (69.6)     2843 (7.4)          8880 (23.0)        38 625

   BMI, mean (SD)                           24.86 (9.18)      24.53 (8.34)        24.60 (8.64)       24.78 (8.99)

  Psychological distress, n (%)                                                                      

   No: GHQ score \<4                        37 450 (68.1)     4273 (7.8)          13 253 (24.1)      54 976

   Yes: GHQ score ≥4                        5718 (70.4)       623 (7.7)           1781 (21.9)        8122
  -------------------------------------------------------------------------------------------------------------------

Smoking status was based on one question with the following options: never, ex-regular smoker, ex-occasional smoker, current smoker. Alcohol use was derived from the question "On how many days in the last 7 days did you have an alcoholic drink?". Long standing illness included at least one illness from a list of body systems (ie, nervous system, heart and circulatory system). The definition of psychological distress was based on the General Health Questionnaire (GQH) comprising 12 questions related with psychological health.

BMI, body mass index; MVPA, moderate-to-vigorous physical activity; max, maximal; y, years.

All-cause mortality {#s3-1}
-------------------

[Table 2](#T2){ref-type="table"} presents the associations between the proportion of MVPA weighted by vigorous activity and all-cause mortality. Of the 64 913 participants, 5064 deaths were registered during 435 743 person-years of follow-up (mean (SD) follow-up, 9.0 (93.6) years). In the whole sample, compared with those not engaging in any vigorous activity (0%), the adjusted HR for all-cause mortality was as follows: HR=0.84 (95% CI 0.71, 0.99) for participants reporting between \>0 and \<30% of MVPA as vigorous; and HR=0.84 (95% CI 0.76, 0.94) for those reporting ≥30% of MVPA as vigorous. In men, the adjusted HR=0.88 (95% CI 0.71, 1.10) in the group \>0 to\<30%, and HR=0.81 (95% CI 0.70, 0.93) in the group ≥30% of MVPA as vigorous activity. In women, HR=0.77 (95% CI 0.58, 1.01) and HR=0.90 (95% CI 0.77, 1.05), respectively. The beneficial associations observed with vigorous activity were attenuated with age. For example, for those who reported 30% or more of MVPA as vigorous activity, the adjusted HR for all-cause mortality was 0.73 (95% CI 0.59, 0.91) in participants aged 30--49 years old versus HR=0.93 (95% CI 0.79 to 1.10) in participants aged ≥65 years. Regardless of whether individuals met physical activity guidelines or not, vigorous physical activity showed protective effects on all-cause mortality risk. For example, we found a 15% risk reduction (HR=0.85, 95% CI 0.74, 0.98) in participants who achieved the recommended 150 min of MVPA and reported 30% or more of vigorous activity; and a 12% non-statistically significant reduction (HR=0.88, 95% CI 0.74, 1.05) in those that did not meet the physical activity guidelines.

###### 

Stratified Cox regression (by age, sex, education and smoking) describing associations between vigorous activity and all-cause mortality

  Proportion of moderate to vigorous activity classified as vigorous                                                                                         
  -------------------------------------------------------------------- ------------- ------------- --- ---------- ----------------------------- ------------ -----------------------------
  All sample                                                           64 913/5064   44 521/4477   1   5000/151   0.84 (0.71 to 0.99) p=0.04    15 392/436   0.84 (0.76 to 0.94) p=0.002
  All sample (excluding first 24 months of death)                      64 186/4507   43 924/3986   1   4972/135   0.84 (0.70 to 1.01) p=0.05    15 290/386   0.85 (0.76 to 0.95) p=0.005
  Sex                                                                                                                                                        
   Men                                                                 28 567/2630   18 421/2296   1   2341/94    0.88 (0.71 to 1.10) p=0.28    7805/240     0.81 (0.70 to 0.93) p=0.003
   Women                                                               36 346/2434   26 100/2181   1   2659/57    0.77 (0.58 to 1.01) p=0.06    7587/196     0.90 (0.77 to 1.05) p=0.19
  Age group, y                                                                                                                                               
   30--49                                                              34 908/606    20 363/431    1   3521/58    0.95 (0.71 to 1.27) p=0.74    11 024/117   0.73 (0.59 to 0.91) p=0.006
   50--64                                                              19 056/1388   14 441/1181   1   1202/51    0.74 (0.55 to 0.98) p=0.04    3413/156     0.84 (0.71 to 1.01) p=0.05
   ≥65                                                                 10 949/3070   9717/2865     1   277/42     0.81 (0.59 to 1.11) p=0.20    955/163      0.93 (0.79 to 1.10) p=0.38
  Weighted MVPA, min/week                                                                                                                                    
   10--149                                                             26 991/2888   23 126/2719   1   485/18     0.91 (0.56 to 1.48) p=0.71    3380/151     0.88 (0.74 to 1.05) p=0.147
   \>150                                                               37 895/2149   21 395/1758   1   4515/133   0.87 (0.72 to 1.04) p=0.132   11 985/258   0.85 (0.74 to 0.98) p=0.02

For all sample values were adjusted for alcohol consumption, total weighted volume of moderate-to-vigorous physical activity (MVPA) and longstanding illness.

N, total population; No, number.

CVD mortality {#s3-2}
-------------

[Table 3](#T3){ref-type="table"} shows point estimates and CIs between the proportion of MVPA as vigorous activity and CVD-mortality risk. In the whole sample, the adjusted HRs were HR=0.83 (95% CI 0.57 to 1.18) and HR=0.84 (95% CI 0.68 1.04) for participants reporting \>0% to \<30% and ≥30%, respectively. However, estimates were imprecise as indicated by their wide CIs (eg, in women HR=0.61 (95% CI 0.30, 1.25) in the category group \>0% to \<30% of MVPA by vigorous activity). In analyses stratified by age, there was weak evidence for associations, despite in the youngest group with ≥30% of MVPA as vigorous, the risk of CVD was 41% lower (95% CI 0.36 to 0.97). Stratifying participants by adherence to the physical activity recommendations showed no evidence of association in most subgroups, with the only exception of meeting activity guidelines and ≥30% of their MVPA as vigorous (HR=0.71, 95% CI 0.53, 0.97).

###### 

Stratified Cox regression (by age, sex, education and smoking) describing associations between vigorous activity and cardiovascular (CVD) mortality

  Proportion of moderate to vigorous activity classified as vigorous                                                                                       
  -------------------------------------------------------------------- ------------- ------------- --- --------- ---------------------------- ------------ -----------------------------
  All sample                                                           57 702/1393   39 913/1252   1   4316/35   0.83 (0.57 to 1.18) p=0.31   13 473/106   0.84 (0.68 to 1.04) p=0.11
  All sample (excluding first 24 months of death)                      57 119/1270   39408/1142    1   4296/32   0.83 (0.57 to 1.20) p=0.32   13 415/96    0.84 (0.67 to 1.05) p=0.126
  Sex                                                                                                                                                      
   Men                                                                 25 381/766    16 528/676    1   2023/27   0.94 (0.63 to 1.41) p=0.76   6830/63      0.78 (0.60 to 1.03) p=0.08
   Women                                                               32 321/627    23 385/576    1   2293/8    0.61 (0.30 to 1.25) p=0.18   6643/43      0.94 (0.68 to 1.31) p=0.72
  Age group, y                                                                                                                                             
   30--49                                                              30 760/124    18 126/92     1   047/10    0.71 (0.36 to 1.39) p=0.31   9587/22      0.59 (0.36 to 0.97) p=0.04
   50--64                                                              17 209/311    13 141/263    1   1037/9    0.63 (0.32 to 1.23) p=0.17   3031/39      0.96 (0.68 to 1.36) p=0.84
   ≥65                                                                 9733/958      8646/897      1   232/16    0.79 (0.48 to 1.30) p=0.35   855/45       0.65 (0.48 to 0.88) p=0.005
  Weighted MVPA, min/week                                                                                                                                  
   10--149                                                             24 500/850    20 999/795    1   439/4     0.82 (0.29 to 2.27) p=0.70   3062/51      1.05 (0.77 to 1.43) p=0.75
   \>150                                                               33 202/543    18 914/457    1   3877/31   0.84 (0.57 to 1.25) p=0.39   10 411/55    0.71 (0.53 to 0.97) p=0.03

For all sample values were adjusted for alcohol consumption, total weighted volume of moderate-to-vigorous physical activity (MVPA), longstanding illness and CVD diagnosis at baseline.

N, total population; No, number.

Cancer mortality {#s3-3}
----------------

[Table 4](#T4){ref-type="table"} shows results of the analyses with cancer mortality as the outcome. In the whole sample, there was weak evidence of vigorous activity being associated with lower cancer mortality risk: HR=0.79 (95% CI 0.60, 1.06) and HR=0.89 (95% CI 0.75, 1.06) for participants reporting \>0% to \<30% and ≥30% of MVPA as vigorous, respectively. However, in most subgroup analyses estimates were less consistent and pointed towards no association. In analyses stratified by sex, there was evidence of a beneficial association of a high proportion of vigorous activity with cancer mortality risk HR=0.83 (95% CI 0.65, 1.05) only in men. In analyses stratified by age, we found evidence of an association with cancer mortality only among participants aged 50--65 years: HR=0.66 (95% CI 0.43, 1.04) and HR=0.77 (95% CI 0.60, 1.00) for \>0% to \<30% and ≥30%, respectively.

###### 

Stratified Cox regression (by age, sex, education and smoking) describing associations between vigorous activity and cancer mortality

  Proportion of moderate to vigorous activity classified as vigorous                                                                                        
  -------------------------------------------------------------------- ------------- ------------- --- ---------- ---------------------------- ------------ ----------------------------
  All sample                                                           63 677/1602   43 576/1384   1   4936/53    0.79 (0.60 to 1.06) p=0.12   15 165/165   0.89 (0.75 to 1.06) p=0.20
  All sample (excluding first 24 months of death)                      63 018/1447   43 039/1247   1   4912/51    0.83 (0.62 to 1.11) p=0.21   15 067/149   0.89 (0.74 to 1.06) p=0.20
  Sex                                                                                                                                                       
   Men                                                                 2 8111/805    18 068/692    1   2315/29    0.83 (0.56 to 1.22) p=0.34   7728/84      0.83 (0.65 to 1.05) p=0.13
   Women                                                               35 566/797    25 508/692    1   2621/24    0.78 (0.51 to 1.19) p=0.25   7437/81      0.98 (0.77 to 1.25) p=0.86
  Age group, y                                                                                                                                              
   30--49                                                              34 593/218    20 166/154    1   3491/21    0.96 (0.60 to 1.55) p=0.87   10 936/43    0.78 (0.54 to 1.11) p=0.17
   50--64                                                              18 593/612    14 093/523    1   1180/21    0.66 (0.43 to 1.04) p=0.07   3320/68      0.77 (0.60 to 1.00) p=0.05
   ≥65                                                                 10 491/772    9317/707      1   265/11     0.65 (0.36 to 1.19) p=0.16   909/54       0.97 (0.74 to 1.29) p=0.86
  Weighted MVPA, min/week                                                                                                                                   
   10--149                                                             26 991/2888   23 126/2719   1   485/18     0.67 (0.27 to 1.67) p=0.39   3380/151     0.90 (0.66 to 1.21) p=0.47
   \>150                                                               37 895/2149   21 95/1758    1   4515/133   0.85 (0.62 to 1.15) p=0.30   11 985/258   0.93 (0.75 to 1.16) p=0.54

For all sample values adjusted for alcohol consumption, total weighted volume of moderate-to-vigorous physical activity (MVPA), longstanding illness and baseline cancer diagnosis at baseline.

N, total population; No, number.

Sensitivity analyses {#s3-4}
--------------------

[Online supplementary table 1](#SP1){ref-type="supplementary-material"} includes the same statistical models of survival analyses previously used but adjusted for other covariates. Model 1 was additionally adjusted for BMI. Model 2 included model 1 plus psychological distress. Results did not change the pattern of the findings shown in [tables 2--4](#T2 T3 T4){ref-type="table"}.
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When using an alternative categorisation of the proportion of MVPA as vigorous (0%,\>0 to \<60%, ≥60%) ([online supplementary table 2](#SP2){ref-type="supplementary-material"}), which was more balanced in terms of group sample size, we found that only low to moderate proportions of vigorous activity (\>0 to \<60%) were associated with lower mortality risk (for all causes, CVD and cancer). Similarly, when we explored another simple indicator of intensity (highest PA intensity achieved), vigorous intensity was again associated with lower mortality risk ([online supplementary table 3](#SP3){ref-type="supplementary-material"}).

Discussion {#s4}
==========

Principal findings {#s4-1}
------------------

Using pooled data from 11 cohorts from England and Scotland, we examined the association between different relative proportions of vigorous physical activity and all-cause, CVD and cancer mortality risk. Our overall findings support the hypothesis that activities of vigorous activity may provide additional reductions in mortality risk (ie, 16% risk reduction for all-cause mortality), in line with results obtained elsewhere,[@R23] yet for cause-specific mortality (CVD, cancer) uncertainty arose as point estimates were wider and crossed the unity.

In contrast to a previous study,[@R23] we did not find evidence of a dose--response reduction in mortality risk with a larger proportion of vigorous activity, which is in line with other studies.[@R22] It must be noted, however, that the benefits of vigorous activity in all-cause mortality risk were restricted to young and middle-aged participants, unlike a previous study where the benefits were independent of the age of participants.[@R23] The null association observed in older adults in the present study could be due to their low physical activity levels. For example, in the study of Gebel *et al,* [@R23] 61% of participants aged 65--75 years reported no vigorous activity vs 89% in the current study (see [table 1](#T1){ref-type="table"}).

For CVD mortality ([table 2](#T2){ref-type="table"}), we found weak evidence linking vigorous activity with additional reductions in mortality risk. The protective CVD effect of vigorous intensity was only observed in men in agreement with data found in Shiroma *et al*.[@R22] We noted that the benefits were mainly accrued to 'any vigorous activity' (the 0%--30% vigorous activity group). The categorisation of the exposure variable was directly comparable to studies published in Australia[@R23] and Japan,[@R24] but this posed some analytical challenges as there was a relatively small number of participants in the middle group category (\>0% to \<30% of MVPA by vigorous activity). In sensitivity analysis where an alternative categorisation of the VPA exposure variable was used to elicit exactly balanced sample sizes between groups ([online supplementary table 2](#SP2){ref-type="supplementary-material"}), we found evidence of beneficial associations for the middle category (\>0 to \<60% of MVPA by vigorous activity) on all-cause and cancer mortality, but with the highest doses of vigorous activity (≥60% of MVPA), the protective associations found with all outcomes were not statistically significant. The hypothesis that an excessive amount of exercise at high intensity could adversely affect cardiac function and increase CVD mortality risk is a topic of debate,[@R31] but this hypothesis is not supported by the results of our observational study.

Regarding cancer mortality, we found inconsistent results (evidence of a protective association with the whole sample, but weak evidence across subgroup analyses). These uncertainties seem concordant with the limited evidence of the preventive role of physical activity on many cancer sites.[@R32] Another limitation in our analysis is that all cancer deaths were pooled into one outcome variable. Future studies about this topic should explore associations between intensities of physical activity and incidence and mortality of cancer-specific sites.

Strengths and limitations of the study {#s4-2}
--------------------------------------

Our study included cause-specific death records from a series of large, nationally representative cohorts. In large cohort studies,[@R23] physical activity data are commonly collected by questionnaires which may lead to recall biases.[@R33] [@R34] However, vigorous activity is considered a more accurate reported variable compared with activities of lower intensity.[@R34] To minimise the risk that our findings could be explained by reverse causation, the reference category in our analyses included those with some moderate physical activity (but no vigorous activity) based on a previous study.[@R23] A recent study from Japan[@R24] included the two different comparator groups (physically inactive and moderate intensity active groups), and larger effect sizes were observed using the inactive group as reference. Nonetheless, given the limitations inherent in any observational study, we cannot totally discard that our associations may have been biased. A lack of adjustment for unknown confounders (ie, dietary factors, undetected comorbidities) may challenge the internal validity of our findings. We also excluded all deaths during the first 2 years of follow-up and the results remained broadly the same. However, future epidemiological studies should employ more strict criteria to control for reverse causation (ie, excluding participants after the first 4 or 6 years of follow-up).

Public health implications {#s4-3}
--------------------------

Although the first public health goal is to meet physical activity guidelines (regardless of the intensity achieved), our data indicate that a single estimate of vigorous activity in adulthood is associated with lower mortality risk compared with activities of moderate intensity. Finally, our stratified analysis also supports the importance of accumulating a minimal amount of activity for health purposes because in participants who achieved less than 150 weekly minutes of MVPA, vigorous activity was not associated with lower mortality.

We conclude that holding constant the amount of physical activity, vigorous activity may confer larger reductions in mortality risk than activities of moderate intensity.

Patient and public involvement {#s4-4}
------------------------------
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